Paper Details

  1. Home
  2. Paper Details

Step-down compared to fixed-dose treatment with inhaled fluticasone propionate in asthma.

Author: ChettaAlfredo, D'IppolitoRaffaele, ForesiAntonio, MastropasquaBerardino, OlivieriDario, PelucchiAndrea, TestiRenato

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Inhaled corticosteroids (ICSs) are effective for asthma even at low doses. Once asthma is controlled, it's recommended to reduce the ICS dose to the lowest possible effective level. While the best way to reduce the dose isn't fully established, measuring eosinophils in sputum (mucus) and bronchial hyperresponsiveness (how sensitive the airways are) can help determine asthma control.
Paper Details　
Original Abstract of the Article :
Inhaled corticosteroids (ICSs) are an effective treatment of asthma even when administered at a low dose. Once asthma is controlled, current guidelines recommend that the dose of ICS be reduced to the lowest possible and effective dose. Although the most appropriate strategy for the stepping down ha...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1378/chest.127.1.117

データ提供：米国国立医学図書館（NLM）

Stepping Down Inhaled Corticosteroids for Asthma Management

The world of asthma management is a complex landscape, with various treatments and strategies aimed at achieving control. This study investigates the effectiveness of stepping down the dose of inhaled corticosteroids (ICSs) once asthma is under control. ICSs, like a cool desert breeze, help soothe inflamed airways, but the question remains: is a fixed-dose approach better than gradually reducing the dose? The authors explored this question by evaluating the role of sputum eosinophils and bronchial hyperresponsiveness (BHR) as indicators of asthma control.

Tailoring Asthma Treatment with Careful Monitoring

The study suggests that stepping down ICSs can be a viable approach, but careful monitoring is key. Sputum eosinophils and BHR, like reliable desert landmarks, can help clinicians track asthma control and adjust treatment accordingly. The authors emphasize that the optimal strategy for stepping down ICSs remains to be fully defined and requires further research.

A Breath of Fresh Air for Asthma Patients

This research offers a glimmer of hope for asthma patients who are seeking ways to minimize their reliance on medications. The findings suggest that with careful monitoring and personalized approaches, it may be possible to reduce ICS doses while maintaining asthma control. This could lead to improved quality of life and reduced side effects for patients.

Dr. Camel's Conclusion

While the quest for the ideal asthma management strategy continues, this study provides valuable insights into the potential of stepping down ICSs. It's like finding a hidden oasis amidst the desert of asthma research, offering a promising path towards better control and quality of life for patients. This research reinforces the importance of careful monitoring and individualized care in managing asthma.

Date :
  1. Date Completed 2005-02-22
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

15653971

DOI: Digital Object Identifier

10.1378/chest.127.1.117

Related Literature

Article Analysis
・Effective treatment of asthma
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.